메뉴 건너뛰기




Volumn 20, Issue 21, 2014, Pages 6691-6697

Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer

Author keywords

Bevacizumab; Colorectal cancer; Coma; Hypertension; Reversible posterior leukoencephalopathy syndrome

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; HYDROCHLOROTHIAZIDE; IRINOTECAN; OXALIPLATIN; SPIRONOLACTONE; UNCLASSIFIED DRUG; URADIL HYDROCHLORIDE; ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

EID: 84902096067     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i21.6691     Document Type: Article
Times cited : (13)

References (15)
  • 3
    • 39149108869 scopus 로고    scopus 로고
    • Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: Updated results from the BICC-C study
    • [PMID: 18235136 DOI: 10.1200/ JCO.2007.15.5390]
    • Fuchs CS, Marshall J, Barrueco J. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study. J Clin Oncol 2008; 26: 689-690 [PMID: 18235136 DOI: 10.1200/ JCO.2007.15.5390]
    • (2008) J Clin Oncol , vol.26 , pp. 689-690
    • Fuchs, C.S.1    Marshall, J.2    Barrueco, J.3
  • 4
    • 0017168828 scopus 로고
    • Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study
    • [PMID: 184880 DOI: 10.1016/0006-8993(76)9035 6-5]
    • Edvinsson L, Owman C, Sjöberg NO. Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res 1976; 115: 377-393 [PMID: 184880 DOI: 10.1016/0006-8993(76)9035 6-5]
    • (1976) Brain Res , vol.115 , pp. 377-393
    • Edvinsson, L.1    Owman, C.2    Sjöberg, N.O.3
  • 5
    • 78649422002 scopus 로고    scopus 로고
    • Posterior reversible encephalopathy syndrome and venous thrombosis
    • [PMID: 21111130 DOI: 10.1016/j.rcl.2010.07.016]
    • Petrovic BD, Nemeth AJ, McComb EN, Walker MT. Posterior reversible encephalopathy syndrome and venous thrombosis. Radiol Clin North Am 2011; 49: 63-80 [PMID: 21111130 DOI: 10.1016/j.rcl.2010.07.016]
    • (2011) Radiol Clin North Am , vol.49 , pp. 63-80
    • Petrovic, B.D.1    Nemeth, A.J.2    McComb, E.N.3    Walker, M.T.4
  • 6
    • 84859908843 scopus 로고    scopus 로고
    • Bevacizumab in combination with irinotecan, 5-fluorouracil and leucovorin given as first-line treatment of metastatic colorectal cancer
    • [PMID: 21768795 DOI: 10.1097/01. cad.0000398727.68461.77]
    • Rocha JA. Bevacizumab in combination with irinotecan, 5-fluorouracil and leucovorin given as first-line treatment of metastatic colorectal cancer. Anticancer Drugs 2011; 22 Suppl 2: S9-S13 [PMID: 21768795 DOI: 10.1097/01. cad.0000398727.68461.77]
    • (2011) Anticancer Drugs , vol.22 , Issue.SUPPL. 2
    • Rocha, J.A.1
  • 8
    • 33644586050 scopus 로고    scopus 로고
    • Reversible posterior leukoencephalopathy syndrome and bevacizumab
    • discussion 980-982 [PMID: 16510760 DOI: 10.1056/NEJMc052954]
    • Glusker P, Recht L, Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006; 354: 980-982; discussion 980-982 [PMID: 16510760 DOI: 10.1056/NEJMc052954]
    • (2006) N Engl J Med , vol.354 , pp. 980-982
    • Glusker, P.1    Recht, L.2    Lane, B.3
  • 9
    • 33750344252 scopus 로고    scopus 로고
    • Bevacizumab in the treatment of metastatic colorectal cancer: Safety profile and management of adverse events
    • [PMID: 17145522 DOI: 10.1053/j.seminoncol.2006.08.001]
    • Hurwitz H, Saini S. Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events. Semin Oncol 2006; 33: S26-S34 [PMID: 17145522 DOI: 10.1053/j.seminoncol.2006.08.001]
    • (2006) Semin Oncol , vol.33
    • Hurwitz, H.1    Saini, S.2
  • 10
    • 25644449640 scopus 로고    scopus 로고
    • Pathophysiological consequences of VEGF-induced vascular permeability
    • [PMID: 16177780 DOI: 10.1038/nature03987]
    • Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005; 437: 497-504 [PMID: 16177780 DOI: 10.1038/nature03987]
    • (2005) Nature , vol.437 , pp. 497-504
    • Weis, S.M.1    Cheresh, D.A.2
  • 11
    • 39649097820 scopus 로고    scopus 로고
    • Reversible posterior leukoencephalopathy syndrome and intravenous bevacizumab
    • [PMID: 18290962 DOI: 10.1111/j.1442-9071.2007.01658.x]
    • Peter S, Hausmann N, Schuster A, Boehm HF. Reversible posterior leukoencephalopathy syndrome and intravenous bevacizumab. Clin Experiment Ophthalmol 2008; 36: 94-96 [PMID: 18290962 DOI: 10.1111/j.1442-9071.2007.01658.x]
    • (2008) Clin Experiment Ophthalmol , vol.36 , pp. 94-96
    • Peter, S.1    Hausmann, N.2    Schuster, A.3    Boehm, H.F.4
  • 12
    • 49749145903 scopus 로고    scopus 로고
    • Reversible posterior leukoencephalopathy syndrome caused by bevacizumab: Report of a case
    • [PMID: 18470563 DOI: 10.1007/s10350-008-9282-8]
    • Koopman M, Muller EW, Punt CJ. Reversible posterior leukoencephalopathy syndrome caused by bevacizumab: report of a case. Dis Colon Rectum 2008; 51: 1425-1426 [PMID: 18470563 DOI: 10.1007/s10350-008-9282-8]
    • (2008) Dis Colon Rectum , vol.51 , pp. 1425-1426
    • Koopman, M.1    Muller, E.W.2    Punt, C.J.3
  • 13
    • 33749587286 scopus 로고    scopus 로고
    • Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer
    • [PMID: 17030665 DOI: 10.1001/archneur. 63.10.1475]
    • Allen JA, Adlakha A, Bergethon PR. Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer. Arch Neurol 2006; 63: 1475-1478 [PMID: 17030665 DOI: 10.1001/archneur. 63.10.1475]
    • (2006) Arch Neurol , vol.63 , pp. 1475-1478
    • Allen, J.A.1    Adlakha, A.2    Bergethon, P.R.3
  • 14
    • 4243057261 scopus 로고    scopus 로고
    • Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies
    • [PMID: 15307110 DOI: 10.1002/ajh.20147]
    • Tam CS, Galanos J, Seymour JF, Pitman AG, Stark RJ, Prince HM. Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies. Am J Hematol 2004; 77: 72-76 [PMID: 15307110 DOI: 10.1002/ajh.20147]
    • (2004) Am J Hematol , vol.77 , pp. 72-76
    • Tam, C.S.1    Galanos, J.2    Seymour, J.F.3    Pitman, A.G.4    Stark, R.J.5    Prince, H.M.6
  • 15
    • 66949140795 scopus 로고    scopus 로고
    • Understanding and managing the possible adverse effects associated with bevacizumab
    • [PMID: 19451611 DOI: 10.2146/ajhp080455]
    • Shord SS, Bressler LR, Tierney LA, Cuellar S, George A. Understanding and managing the possible adverse effects associated with bevacizumab. Am J Health Syst Pharm 2009; 66: 999-1013 [PMID: 19451611 DOI: 10.2146/ajhp080455]
    • (2009) Am J Health Syst Pharm , vol.66 , pp. 999-1013
    • Shord, S.S.1    Bressler, L.R.2    Tierney, L.A.3    Cuellar, S.4    George, A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.